結晶型硫酸鹽葡萄糖胺 – 骨科醫生推薦No.1 藥物*


  • 參考資料PM-VIS-24-042302 May 2024

    1. Viartril®-S Capsules 250 mg & 500mg Package Insert. Version L1086D.
    2. Viartril®-S Sachets 1500mg Package Insert. Version L1019F.
    3. Eriksen P, et al. Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials. Arthritis Care Res (Hoboken). 2014;66(12):1844-1855.
    4. Patterson A. The development and validation of a near infrared application for the qualitative identification of Plantago ovata husk granules. NIR news. 2013;24(1):8-10.
    5. Buyere O, et al. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S12-S17.
    6. Sun Y, et al. Repairing effects of glucosamine sulfate in combination with etoricoxib on articular cartilages of patients with knee osteoarthritis. J Orthop Surg Res. 2020;15(1):150.
    7. Viartril®-S capsules 314 mg registration. Hong Kong Department of Health. 2024. Available at: Accessed on April 23, 2024.
    8. Persiani S, et al. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Oesteoarth. Cartilage. 2005; 13: 1041-1049.
    9. Kucharz E, et al. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin. 2016; 32(6): 997-1004.
    10. Buyere O, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(4 Suppl):S3-S11.